Evolus Submits PMA to FDA for Evolysse Sculpt, an HA Filler That Restores Mid-face Volume
Evolus, Inc. has submitted the final module of its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Evolysse Sculpt, an injectable hyaluronic acid (HA) gel for restoring mid-face volume.